The mTOR Inhibitor Rapamycin Synergizes with a Fatty Acid Synthase Inhibitor to Induce Cytotoxicity in ER/HER2-Positive Breast Cancer Cells
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference41 articles.
1. Breast cancer statistics,2013;C Desantis;CA Cancer J Clin,2014
2. Comprehensive molecular portraits of human breast tumours;Network Cancer Genome Atlas;Nature,2012
3. Strategies for subtypes-dealing with thediversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer;A Goldhirsch;Ann Oncol,2011
4. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer;MC Cheang;J Natl Cancer Inst,2009
5. Histological grade as an alternative to the Ki67 labeling index is only available for luminal-type breast cancers;S Hayashi;Breast Cancer,2014
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Valproic acid targets IDH1 mutants through alteration of lipid metabolism;npj Metabolic Health and Disease;2024-08-13
2. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle‐related genes and miRNAs in triple‐negative breast cancer cells;Molecular Carcinogenesis;2023-10-03
3. Malonyl-CoA is a conserved endogenous ATP-competitive mTORC1 inhibitor;Nature Cell Biology;2023-08-10
4. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies;Oncogenesis;2023-03-18
5. Molecular Mechanisms of Breast Cancer Metastasis;Cancer Metastasis - Molecular Mechanism and Clinical Therapy;2023-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3